Primus Remedies Private Limited, a active private limited company, was established on 26 February 2010 in Dombivili, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232MH2010PTC200506. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 292 professional, Its leadership includes Srinivas Gangashettywar (Director), Rakesh Pasupunuri (Director), Jonnalagadda Venkata Nagendraprasad (Director). It holds ₹17.91 Cr open charges and ₹3.53 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-16, Ankur Co-Operative Society Thakurli East, Dombivili, Maharashtra, 421201.
U24232MH2010PTC200506
200506
26 February 2010
₹4.00 Cr
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Primus Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Gangashettywar | Director | 26 Feb 2010 | Current |
| Rakesh Pasupunuri | Director | 03 Jun 2022 | Current |
| Jonnalagadda Venkata Nagendraprasad | Director | 03 Jun 2022 | Current |
| Kavitha Gangashettwar | Director | 03 Jun 2022 | Current |
| Satya Surya Purna Prasanthi Narayanam | Director | 03 Jun 2022 | Current |
| Swapna Pasupunuri | Director | 26 Feb 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Primus Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.96% increase. The company also saw a slight improvement in profitability, with a 2.18% increase in profit. The company's net worth Soared by an impressive increase of 32.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Primus Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹179,050,000.00
₹3,529,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2025 | Others | ₹4.50 M | Open |
| 26 Jul 2025 | Others | ₹8.30 M | Open |
| 17 Jun 2025 | Hdfc Bank Limited | ₹1.90 M | Open |
| 03 Nov 2021 | Axis Bank Limited | ₹4.45 M | Open |
| 18 Oct 2021 | Axis Bank Limited | ₹2.40 M | Open |
Explore comprehensive loan charge details -
Primus Remedies has a workforce of 292 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Primus Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primus Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.45 Cr with Charge ID 101157472 was registered on 26 Jul 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.83 Cr with Charge ID 101155908 was registered on 26 Jul 2025. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.19 Cr with Charge ID 101149724 was registered on 17 Jun 2025. was documented.
A charge with Axis Bank Limited of Rs. 15.00 Cr registered on 25 Oct 2019 with Charge ID 100301053 was modified on 31 Jan 2025. was recorded as a recent event.
Primus Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Primus Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The CIN of Primus Remedies Private Limited is U24232MH2010PTC200506.
Primus Remedies Private Limited is headquartered at C-16, Ankur Co-Operative Society Thakurli East, Dombivili, Maharashtra, 421201.
Primus Remedies Private Limited was incorporated on 26 February 2010.
The current directors of Primus Remedies Private Limited are
The primary industry of Primus Remedies Private Limited is Trade.
Primus Remedies Private Limited is unlisted.
The authorized capital of Primus Remedies Private Limited is ₹4.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Primus Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX